CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-14 | Ahlholm Frederick W SVP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2016-12-12 | Ollier Michele Director | Option exercise | +202,634 | $5.77 | $1.2M | 4,690,906 |
| 2016-12-12 | Ollier Michele Director | Option exercise · Warrant Shares | −202,634 | 0 | ||
| 2016-12-12 | De Rubertis Francesco Director | Option exercise | +202,634 | $5.77 | $1.2M | 4,690,906 |
| 2016-12-12 | De Rubertis Francesco Director | Option exercise · Warrant Shares | −202,634 | 0 | ||
| 2016-12-12 | Index Venture Associates III Ltd 10% owner | Option exercise | +202,634 | $5.77 | $1.2M | 4,690,906 |
| 2016-12-12 | Index Venture Associates III Ltd 10% owner | Option exercise · Warrant Shares | −202,634 | 0 | ||
| 2016-08-10 | De Rubertis Francesco Director | Sale | −1,000,000 | $10.00 | $10.0M | 4,488,272 |
| 2016-08-10 | Ollier Michele Director | Sale | −1,000,000 | $10.00 | $10.0M | 4,488,272 |
| 2016-08-10 | Index Venture Associates III Ltd 10% owner | Sale | −1,000,000 | $10.00 | $10.0M | 4,488,272 |
| 2016-06-21 | Kupfer David Director | Purchase | +27,935 | $10.73 | $300K | 27,935 |
| 2016-06-20 | Kupfer David Director | Purchase | +27,700 | $10.95 | $303K | 209,188 |
| 2016-06-16 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2016-06-16 | Vandervelpen Nico Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2016-06-16 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2016-06-16 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2016-06-16 | Beer Marc D Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2016-03-17 | Kupfer David Director | Purchase | +181,488 | $5.51 | $1000K | 181,488 |
| 2015-12-04 | Levine Mark S. SVP,General Counsel & Sec. | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2015-12-04 | Ahlholm Frederick W SVP, Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 |
Page 15 of 16 · 305 trades